Vasculitis

---

Dysautonomia in a cutaneous polyarteritis nodosa patient: evidence of systemic evolving?

Beyond Rheumatology 2024; 6 (1): e505
DOI: 10.53238/br_20244_505

Takayasu Arteritis: recent advances and clinical pitfalls

Beyond Rheumatology 2022; 4 (2): e400
DOI: 10.53238/br_20228_400

Cryoglobulinemic vasculitis: from aetiology to treatment

Beyond Rheumatology 2022; 4 (2): e396
DOI: 10.53238/br_20228_396

A case report of calcific aterosclerosis demonstrated on 18-F-fluorodeoxyglucose positron emission tomography/computed tomography

Beyond Rheumatology 2021; 3 (3): e315
DOI: 10.4081/br.2021.70

The management of large vessel vasculitides

Beyond Rheumatology 2021; 3 (1): e286
DOI: 10.4081/br.2021.51

Asymptomatic versus symptomatic patients: [18F]FDG-PET/CT patterns and evolutionary track of COVID-19 associated vasculitis

Beyond Rheumatology 2021; 3 (1): e284
DOI: 10.4081/br.2021.45

EULAR guidelines on ANCA-associated vasculitis in the real life

Beyond Rheumatology 2021; 2 (3): e281
DOI: 10.4081/br.2020.50

Practical approach to vasculitides in adults: an overview of clinical conditions that can mimic vasculitides closely

Beyond Rheumatology 2020; 2 (1): e267
DOI: 10.4081/br.2020.20

Buerger’s disease or thromboangiitis obliterans: description of two cases

Beyond Rheumatology 2019; 1 (2): e260
DOI: 10.4081/br.2019.21